Opposing roles of STAT1 and STAT3 in IL-21 function in CD4⁺ T cells

IL-21 is a type I cytokine essential for immune cell differentiation and function. Although IL-21 can activate several STAT family transcription factors, previous studies focused mainly on the role of STAT3 in IL-21 signaling. Here, we investigated the role of STAT1 and show that STAT1 and STAT3 hav...

Full description

Saved in:
Bibliographic Details
Published inProceedings of the National Academy of Sciences - PNAS Vol. 112; no. 30; pp. 9394 - 9399
Main Authors Wan, Chi-Keung, Andraski, Allison B., Spolski, Rosanne, Li, Peng, Kazemian, Majid, Oh, Jangsuk, Samsel, Leigh, Swanson, Phillip A., McGavern, Dorian B., Sampaio, Elizabeth P., Freeman, Alexandra F., Milner, Joshua D., Holland, Steven M., Leonard, Warren J.
Format Journal Article
LanguageEnglish
Published United States National Academy of Sciences 28.07.2015
National Acad Sciences
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:IL-21 is a type I cytokine essential for immune cell differentiation and function. Although IL-21 can activate several STAT family transcription factors, previous studies focused mainly on the role of STAT3 in IL-21 signaling. Here, we investigated the role of STAT1 and show that STAT1 and STAT3 have at least partially opposing roles in IL-21 signaling in CD4⁺ T cells. IL-21 induced STAT1 phosphorylation, and this was augmented inStat3-deficient CD4⁺ T cells. RNA-Seq analysis of CD4⁺ T cells fromStat1-andStat3-deficient mice revealed that both STAT1 and STAT3 are critical for IL-21–mediated gene regulation. Expression of some genes, includingTbx21andIfng, was differentially regulated by STAT1 and STAT3. Moreover, opposing actions of STAT1 and STAT3 on IFN-γexpression in CD4⁺ T cells were demonstrated in vivo during chronic lymphocytic choriomeningitis infection. Finally, IL-21–mediated induction of STAT1 phosphorylation, as well asIFNGandTBX21expression, were higher in CD4⁺ T cells from patients with autosomal dominant hyper-IgE syndrome, which is caused by STAT3 deficiency, as well as in cells from STAT1 gain-of-function patients. These data indicate an interplay between STAT1 and STAT3 in fine-tuning IL-21 actions.
Bibliography:SourceType-Scholarly Journals-1
ObjectType-Feature-1
content type line 14
ObjectType-Article-1
ObjectType-Feature-2
content type line 23
2Present address: Department of Nutrition, Harvard T.H. Chan School of Public Health, Boston, MA 02115.
Author contributions: C.-K.W., A.B.A., P.L., and W.J.L. designed research; C.-K.W., A.B.A., R.S., P.L., M.K., J.O., L.S., P.A.S., E.P.S., and A.F.F. performed research; C.-K.W., A.B.A., R.S., P.L., M.K., D.B.M., and W.J.L. analyzed data; and C.-K.W., A.B.A., P.L., D.B.M., J.D.M., S.M.H., and W.J.L. wrote the paper.
Reviewers: T.R.M., Miller School of Medicine, University of Miami; and H.A.Y., National Cancer Institute.
Contributed by Warren J. Leonard, June 18, 2015 (sent for review May 19, 2015; reviewed by Thomas R. Malek and Howard A. Young)
1C.-K.W., and A.B.A. contributed equally to this work.
ISSN:0027-8424
1091-6490
1091-6490
DOI:10.1073/pnas.1511711112